---
$id: https://graph.org.ai/products/commodity/51343506
$type: Product
source: UNSPSC
code: "51343506"
title: "Cidofovir anhydrous"
class: "51343500"
classTitle: "Antiviral organophosphorus compounds"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cidofovir anhydrous

**UNSPSC Code**: 51343506
**Class**: [Antiviral organophosphorus compounds](Antiviral organophosphorus compounds.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiviral agent with the molecular formula C8H14N3O6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 768M1V522C, chemically known as phosphonic acid, ((2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, (s)-, but more generally known as cidofovir anhydrous, which bears US NIH Compound Identifier 60613. European Medicines Agency schedules cidofovir anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06257MIG. Most nations, for tariff purposes, schedule cidofovir anhydrous under HS 29335995. Cidofovir anhydrous bears US NLM identifiers UMLS ID C2699210 and NCI Concept Code C77925. SMILES: C1CN(C(=O)NC1N)C[C@@H](CO)OCP(=O)(O)O.

